Prostatic Health Status Index.

Authors

Saul Boyarsky, Washington University School of Medicine in St. Louis
Robert Woodward, University of New Hampshire - Main Campus

Abstract

Abstract

A prostatic health status index (PHSI) can serve as a quantitative yardstick for decision-making about costs, money, operative indications, operative results, and the efficacy of drug therapy. We have evolved such an index based on the conventional urological work-up by combining the signs and symptoms and the presence or absence of health for determining the economic implications of benign prostatic hypertrophy (BPH). Cost-effectiveness is the analytical tool most commonly used by economists to measure the efficiency of resource utilization for medical care. Essentially, it asks the question, “Is the money being spent for the best results?”

Department

Health Management and Policy

Publication Date

1983

Publisher

Springer

Digital Object Identifier (DOI)

10.1007/978-1-4612-5476-8_80

Document Type

Book Chapter

Recommended Citation

Boyarsky, S. and Woodward, R.S. “Prostatic Health Status Index." Benign Prostatic Hypertrophy. Frank Hinman, Jr. (ed.), New York: Springer Verlag, 1983. pp 766-770. Print.